Randall H. Kramer, PhD

Education

University of California, Berkeley, B.A., 1971, Biochemistry
Yale University School of Medicine, M.S., 1974, Pharmacology
Yale University School of Medicine, Ph.D., 1977, Pharmacology
University of California, Irvine, Postdoc., 1977-80, Cell Biology

Honors & Awards

• 1983, 1988
  National Institutes of Health, Ad Hoc Reviewer, Pathology B Study Section
• 1984
  International Institute for Microcirculation, Cambridge, England, Research Award
• 1985
  Veterans1 Administration, Career Development Program, Reviewer
• 1986
  National Cancer Institute, Cancer Therapeutics Review Committee, Consultant
• 1987-1989
  National Cancer Institute of Canada, Ad Hoc Reviewer, Panel B
• 1987-1996
  National Science Foundation, Research Grant Program, Reviewer
• 1989
  National Institutes of Health, Pathobiochemistry Study Section, Ad Hoc Reviewer
• 1990, 1994
  National Cancer Institute, Program Project, Ad Hoc Reviewer
• 1990-1993
  Gordon Conference, Basement Membranes, Cell Contact and Adhesion, Invited Speaker
• 1991, 1993
  American Cancer Institute, Advisory Committee on Cell and Developmental Biology
• 1995, 1996, 1999
  Oral Biology and Medicine Study Section, Ad Hoc Reviewer
• 1999, 2004
  NCI Workshop, Head and Neck Cancer
• 2000
  NIDCR Review Panel, Genetic Basis of Oral Cancer
• 2001, 2003
  NIDCR Special Review Panel on Oral Cancer
• 2002, 2004
  NCI Head and Neck SPORE Panel Review
• 2005, 2006
  NIH Tumor Microenvironment Study Section
• 2006
  NIDCR Special Review Panel

Selected Publications

1. Yang F, Xiao W, Liu Y, Liu R, Kramer R, Li X, Ajena Y, Baehr CM, Rojalin T, Zhang H, Lam KS. One-bead one-compound combinatorial library derived targeting ligands for detection and treatment of oral squamous cancer. Oncotarget. 2019 Sep 10; 10(52):5468-5479.  View on PubMed
2. Humtsoe JO, Pham E, Louie RJ, Chan DA, Kramer RH. ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth. Oncogene. 2016 Mar 24; 35(12):1554-64.  View on PubMed
3. Yang F, Liu R, Kramer R, Xiao W, Jordan R, Lam KS. Discovery of specific ligands for oral squamous carcinoma to develop anti-cancer drug loaded precise targeting nanotherapeutics. J Calif Dent Assoc. 2012 Dec; 40(12):939-43.  View on PubMed
4. Humtsoe JO, Koya E, Pham E, Aramoto T, Zuo J, Ishikawa T, Kramer RH. Transcriptional profiling identifies upregulated genes following induction of epithelial-mesenchymal transition in squamous carcinoma cells. Exp Cell Res. 2012 Feb 15; 318(4):379-90.  View on PubMed
5. Zuo J, Ishikawa T, Boutros S, Xiao Z, Humtsoe JO, Kramer RH. Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis. Mol Cancer Res. 2010 Feb; 8(2):170-82.  View on PubMed
6. Ishikawa T, Kramer RH. Sdc1 negatively modulates carcinoma cell motility and invasion. Exp Cell Res. 2010 Apr 01; 316(6):951-65.  View on PubMed
7. Humtsoe JO, Kramer RH. Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway. Oncogene. 2010 Feb 25; 29(8):1214-26.  View on PubMed
8. Pawlikowski B, Lee L, Zuo J, Kramer RH. Analysis of human muscle stem cells reveals a differentiation-resistant progenitor cell population expressing Pax7 capable of self-renewal. Dev Dyn. 2009 Jan; 238(1):138-49.  View on PubMed
9. Gorfu G, Virtanen I, Hukkanen M, Lehto VP, Rousselle P, Kenne E, Lindbom L, Kramer R, Tryggvason K, Patarroyo M. Laminin isoforms of lymph nodes and predominant role of alpha5-laminin(s) in adhesion and migration of blood lymphocytes. J Leukoc Biol. 2008 Sep; 84(3):701-12.  View on PubMed
10. El-Sayed I, Huang X, Macheret F, Humstoe JO, Kramer R, El-Sayed M. Effect of plasmonic gold nanoparticles on benign and malignant cellular autofluorescence: a novel probe for fluorescence based detection of cancer. Technol Cancer Res Treat. 2007 Oct; 6(5):403-12.  View on PubMed
11. Onishi A, Chen Q, Humtsoe JO, Kramer RH. STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells. Exp Cell Res. 2008 Jan 15; 314(2):377-86.  View on PubMed
12. Jethanandani P, Kramer RH. Alpha7 integrin expression is negatively regulated by deltaEF1 during skeletal myogenesis. J Biol Chem. 2005 Oct 28; 280(43):36037-46.  View on PubMed
13. Kramer RH, Shen X, Zhou H. Tumor cell invasion and survival in head and neck cancer. Cancer Metastasis Rev. 2005 Jan; 24(1):35-45.  View on PubMed
14. Zhou H, Kramer RH. Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1. J Biol Chem. 2005 Mar 18; 280(11):10624-35.  View on PubMed
15. Shen X, Kramer RH. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am J Pathol. 2004 Oct; 165(4):1315-29.  View on PubMed
16. Chen Q, Lipkina G, Song Q, Kramer RH. Promoter methylation regulates cadherin switching in squamous cell carcinoma. Biochem Biophys Res Commun. 2004 Mar 19; 315(4):850-6.  View on PubMed
17. Xiao J, Jethanandani P, Ziober BL, Kramer RH. Regulation of alpha7 integrin expression during muscle differentiation. J Biol Chem. 2003 Dec 12; 278(50):49780-8.  View on PubMed
18. Ferguson JW, Thoma BS, Mikesh MF, Kramer RH, Bennett KL, Purchio A, Bellard BJ, LeBaron RG. The extracellular matrix protein betaIG-H3 is expressed at myotendinous junctions and supports muscle cell adhesion. Cell Tissue Res. 2003 Jul; 313(1):93-105.  View on PubMed
19. Yeh MG, Ziober BL, Liu B, Lipkina G, Vizirianakis IS, Kramer RH. The beta1 cytoplasmic domain regulates the laminin-binding specificity of the alpha7X1 integrin. Mol Biol Cell. 2003 Sep; 14(9):3507-18.  View on PubMed
20. Vizirianakis IS, Chen YQ, Kantak SS, Tsiftsoglou AS, Kramer RH. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells. Int J Oncol. 2002 Jul; 21(1):135-44.  View on PubMed

Go to UCSF Profiles, powered by CTSI